Details for Patent: 12,213,983
✉ Email this page to a colleague
Which drugs does patent 12,213,983 protect, and when does it expire?
Patent 12,213,983 protects COPIKTRA and is included in one NDA.
This patent has seventy-four patent family members in thirty countries.
Summary for Patent: 12,213,983
| Title: | Treatment of cancers using PI3 kinase isoform modulators |
| Abstract: | Provided herein are methods, kits, and pharmaceutical compositions that include a PI3 kinase inhibitor for treating cancers or hematologic disorders. |
| Inventor(s): | Howard M. STERN, Jeffrey L. Kutok |
| Assignee: | Infinity Pharmaceuticals Inc |
| Application Number: | US16/848,485 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 12,213,983
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Secura | COPIKTRA | duvelisib | CAPSULE;ORAL | 211155-001 | Sep 24, 2018 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | FOR THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND/OR SMALL LYMPHOCYTIC LEUKEMIA (SLL) | ⤷ Start Trial | ||||
| Secura | COPIKTRA | duvelisib | CAPSULE;ORAL | 211155-002 | Sep 24, 2018 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | FOR THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND/OR SMALL LYMPHOCYTIC LEUKEMIA (SLL) | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,213,983
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2914296 | ⤷ Start Trial | 301141 | Netherlands | ⤷ Start Trial |
| European Patent Office | 2914296 | ⤷ Start Trial | CA 2021 00046 | Denmark | ⤷ Start Trial |
| European Patent Office | 2914296 | ⤷ Start Trial | PA2021527 | Lithuania | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
